Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review
View abstract on PubMed
Summary
This summary is machine-generated.Cell-free nucleic acids (cf-NAs) show promise as biomarkers for peritoneal dialysis (PD) complications. Monitoring bacterial DNA, cell-free DNA, and miRNA in PD effluent can aid diagnosis and treatment strategies.
Area Of Science
- Biomarkers
- Molecular Diagnostics
- Peritoneal Dialysis
Background
- Cell-free nucleic acids (cf-NAs) are established biomarkers in oncology and immunology.
- Peritoneal dialysis (PD) relies on the peritoneal membrane for blood purification.
- Complications of PD, including peritonitis and membrane aging, significantly impact patient management.
Purpose Of The Study
- To review the potential of cf-NAs as biomarkers for monitoring PD and its complications.
- To explore the diagnostic and prognostic value of various cf-NAs in the context of PD.
- To highlight the role of cf-NAs in early detection and management of PD-related issues.
Main Methods
- Review of literature on cf-NAs in peritoneal dialysis effluent (PDE).
- Focus on bacterial DNA, cell-free DNA (cf-DNA), mitochondrial DNA (mtDNA), and microRNA (miRNA).
- Analysis of cf-NA applications in diagnosing and monitoring PD complications.
Main Results
- Bacterial DNA in PDE can facilitate early identification and targeted therapy for acute peritonitis.
- cf-DNA in PDE serves as an indicator of peritoneal membrane stress in acute and chronic PD complications.
- miRNA and mtDNA show potential for detecting peritoneal membrane remodeling, aging, and inflammation.
Conclusions
- cf-NAs represent a promising avenue for the diagnosis and treatment of PD complications.
- Specific cf-NAs like bacterial DNA, cf-DNA, miRNA, and mtDNA can serve as valuable biomarkers in PD.
- Further research is essential to integrate cf-NA analysis into routine clinical practice for PD patients.

